FDMT
#2786
4D Molecular Therapeutics, Inc. - Common Stock
11.7 0 USD
+0.04%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+3.54%
Variación mensual
+27.31%
Variación en los últimos 6 meses
+51.95%
Cambio anual
+3.54%
Cierres anteriores
11.3 0
Open
11.7 0
Mínimo
11.7 0
High
11.7 0
Volumen
72
Financials
- Market Capitalization 611.63 M
- Employee 196
- Founded 2013
- CEO N/A
- Website www.4dmoleculartherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QG40R88
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.62
Relación precio/flujo de caja
6.14
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2778 |  NGNE Neurogene Inc. - Common Stock | 39.08 USD | +1.98% | +6.37% | +30.27% | +32.83% | 617.54 M USD | ||
| 2782 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.34 USD | 0.00% | -7.17% | +8.93% | -23.24% | 615.16 M USD | ||
| 2800 |  FBRX Forte Biosciences, Inc. - Common Stock | 43.20 USD | -2.09% | +96.45% | +139.34% | +47.19% | 599.86 M USD | ||
| 2823 |  IMMX Immix Biopharma, Inc. - Common Stock | 10.68 USD | +1.52% | -8.87% | +25.65% | +278.72% | 581.11 M USD |